PET/CT在胰腺导管腺癌异种移植瘤近距离放疗早期疗效评估中的应用:与弥散加权MRI表观扩散系数的比较
研究将SW1990人胰腺导管腺癌皮下移植于20只裸鼠,随机分为125碘粒子组与空白粒子组,于治疗前及治疗后5天行PET/CT与DW-MRI,计算SUVmax与ADC值。125碘粒子组治疗后SUVmax显著下降、ADC显著升高,空白粒子组无显著差异;治疗前两组SUVmax与ADC均呈显著负相关,125碘粒子治疗后二者无显著相关。作者认为PET/CT与DW-MRI能够监测PDAC异种移植瘤对近距离放疗的早期反应。
要点
- 在PDAC异种移植瘤模型中,125碘粒子治疗后5天SUVmax显著下降、ADC显著升高。
- 治疗前SUVmax与ADC呈显著负相关,提示PET/CT与DW-MRI可能互补。
- 125碘粒子治疗后SUVmax与ADC无显著相关,阅片时不宜以二者变化互相推断。
核心结论
- PET/CT与DW-MRI能够监测PDAC异种移植瘤对近距离放疗的早期反应;治疗前SUVmax与ADC的显著负相关提示PET/CT与DW-MRI可能在该疗效评估中起互补作用。
研究设计与样本
- 动物实验研究,将SW1990人PDAC皮下植入20只裸鼠,随机分为125碘粒子组与空白粒子组,于治疗前及治疗后5天行PET/CT与DW-MRI,分别计算SUVmax与ADC值,采用Pearson相关检验分析二者相关性。
诊断标准与关键数值
- 125碘粒子组治疗前与治疗后5天SUVmax比较P<0.001,两组间比较P<0.001。
- 125碘粒子组治疗前与治疗后5天ADC值比较P<0.001,两组间比较P<0.001。
- 空白粒子组治疗前与治疗后SUVmax比较P=0.057,ADC值比较P=0.397。
- 治疗前两组SUVmax与ADC均呈显著负相关:r=-0.964、R²=0.929、P<0.001;r=-0.917、R²=0.841、P<0.001。
- 空白粒子组治疗后SUVmax与ADC呈显著负相关(r=-0.944、R²=0.891、P<0.001);125碘粒子组治疗后无显著相关(r=-0.388、R²=0.151、P=0.268)。
临床应用与阅片要点
- 在PDAC异种移植瘤模型中,125碘粒子治疗后5天即可见SUVmax下降与ADC升高,提示PET/CT与DW-MRI可用于早期疗效监测。
- 治疗前SUVmax与ADC呈显著负相关,作者认为二者可能互补用于疗效评估。
- 125碘粒子治疗后SUVmax与ADC无显著相关,解读治疗后两种影像指标变化时需注意此点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the feasibility of using PET/CT and diffusion-weighted magnetic resonance imaging (DW-MRI) to monitor the early response of pancreatic ductal adenocarcinoma (PDAC) xenografts to brachytherapy, and to determine whether maximum standardized uptake value (SUVmax) correlate with apparent diffusion coefficient (ADC).
MATERIALS AND METHODS: SW1990 human PDAC were subcutaneously implanted in 20 nude mice. They were randomly divided into 125-Iodine (125I) seeds and blank seeds group. PET/CT and DW-MRI were performed at pretreatment and 5 days after therapy. SUVmax and ADC values were calculated, respectively. The correlation between SUVmax and ADC values was analyzed by the Pearson correlation test.
RESULTS: The SUVmax were significantly decreased between pretreatment and 5 days after 125I seeds treatment (p < 0.001) and between two groups (p < 0.001). And the ADC values were significantly increased between pretreatment and 5 days after 125I seeds treatment (p < 0.001) and between two groups (p < 0.001). While in the bank seeds group, there were no significantly difference between pretreatment and after treatment in SUVmax and ADC values (p = 0.057; p = 0.397). SUVmax and ADC correlated significantly and negatively before treatment in both groups (r = - 0.964, R2 = 0.929, p < 0.001; r = - 0.917, R2 = 0.841, p < 0.001) and after treatment in the blank seeds group (r = - 0.944, R2 = 0.891, p < 0.001). But after 125I seeds treatment there was no significant correlation between SUVmax and ADC (r = - 0.388, R2 = 0.151, p = 0.268).
CONCLUSION: The PET/CT and DW-MRI are capable of monitoring the early response of PDAC xenografts to brachytherapy. The significantly inverse correlation between pretreatment SUVmax and ADC suggests that PET/CT and DW-MRI might play complementary roles for therapy assessment.
引用
- Liu Y, Liu M, Liu X, et al. PET/CT in brachytherapy early response evaluation of pancreatic ductal adenocarcinoma xenografts: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging. Abdom Radiol (NY). 2019. PMID: 30315322. doi:10.1007/s00261-018-1791-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。